Rezolute (RZLT) Operating Income (2012 - 2026)
Rezolute's (RZLT) quarterly Operating Income came in at -$17.4 million in Q1 2026, up 13.27% year-on-year from -$15.3 million in Q1 2025, and up 28.3% quarter-over-quarter from -$24.2 million in Q4 2025.
Rezolute (RZLT) Operating Income (2012 - 2026) Analysis & Trends
Rezolute has disclosed Operating Income across 15 years of filings, most recently posting -$17.4 million for Q1 2026.
- Operating Income for Q1 2026 came in at -$17.4 million, up 13.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.3 million (down 13.1% YoY), and the FY2025 annual result was -$79.9 million, down 13.45% from the prior year.
- Operating Income came in at -$17.4 million for Q1 2026 at Rezolute, up from -$24.2 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$10.2 million in Q3 2022 to a low of -$25.8 million in Q2 2025.
- The 5-year median for Operating Income is -$16.9 million (2024), against an average of -$17.0 million.
- Across the five-year window, Operating Income plunged 96.13% in 2022 and gained 13.27% in 2026, its largest moves.
- Rezolute's Operating Income stood at -$14.4 million in 2022, then slipped by 5.57% to -$15.2 million in 2023, then decreased by 12.41% to -$17.1 million in 2024, then sank by 41.81% to -$24.2 million in 2025, then climbed by 28.3% to -$17.4 million in 2026.
- The last three Operating Income figures came in at -$17.4 million (Q1 2026), -$24.2 million (Q4 2025), and -$19.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -17.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.37 Mn |
| Dec 31, 2025 | -24.22 Mn |
| Sep 30, 2025 | -19.82 Mn |
| Jun 30, 2025 | -25.85 Mn |
| Mar 31, 2025 | -20.02 Mn |
| Dec 31, 2024 | -17.08 Mn |
| Sep 30, 2024 | -16.94 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Mar 31, 2024 | -16.21 Mn |
| Dec 31, 2023 | -15.19 Mn |
| Sep 30, 2023 | -15.91 Mn |
| Jun 30, 2023 | -14.24 Mn |
| Mar 31, 2023 | -17.14 Mn |
| Dec 31, 2022 | -14.39 Mn |
| Sep 30, 2022 | -10.22 Mn |
| Jun 30, 2022 | -11.30 Mn |
| Mar 31, 2022 | -10.75 Mn |
| Dec 31, 2021 | -12.15 Mn |
| Sep 30, 2021 | -7.64 Mn |
| Jun 30, 2021 | -6.64 Mn |